Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Structural Study of the Juxtamembrane Region and Kinase Domain of the c-Met Receptor Tyrosine Kinase
FY 2009-10
Summary
Regulation of events such as cell survival, division or death mainly occurs via molecular signaling. Extracellular messenger molecules bind to cell surface receptor proteins and initiate signaling that determines cell fate. c-Met is one of these proteins. Interest in c-Met comes from its implication in cancer. When this protein is aberrantly activated or mutated, it drives cell proliferation and facilitates metastasis, a dreaded development of cancer. Indeed, mutations in c-Met have been found in some malignancies, including lung adenocarcinomas and small cell lung cancer.
Upon binding of a messenger molecule to c-Met, the protein self-activates and is then able to indirectly switch on other proteins to relay the signal. This is accomplished by a part of c-Met called the kinase domain. Many anticancer drugs function to block the activity of various kinases, by directly binding to that domain. Structural biology has provided us with the 3D structure of c-Met kinase, allowing the characterization of drug-protein interactions at the atomic level. c-Met also has another part called the juxtamembrane region (JMR). The JMR is involved in downregulation of c-Met activity. Part of this regulation is understood, but other aspects are unclear; the JMR can get chemically modified and this event decreases the activity of c-Met kinase. I want to determine the 3D structure of the JMR by x-ray crystallography and study its interaction with the kinase part, in the hope of clarifying how this regulation occurs at the molecular level. I also want to screen a large collection of chemicals to find novel inhibitors of c-Met, since inclusion of the JMR will provide more possibilities for chemical compounds to affect the protein. Understanding how c-Met is regulated would facilitate the development of new molecules to block its function and would ultimately increase our therapeutic arsenal against cancer.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
200309
Name
Gorelik Alexei
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Structural Study of the Juxtamembrane Region and Kinase Domain of the c-Met Receptor Tyrosine Kinase
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
C-Met; High-Throughput Screening; Juxtamembrane; Kinase Inhibitors; Nuclear Megnetic Resonnance; Protein-Protein Interaction; Receptor Activity Regulation; Receptor Tyrosine Kinase; Signal Transduction; X-Ray Crystallography
Abstract
Regulation of events such as cell survival, division or death mainly occurs via molecular signaling. Extracellular messenger molecules bind to cell surface receptor proteins and initiate signaling that determines cell fate. c-Met is one of these proteins. Interest in c-Met comes from its implication in cancer. When this protein is aberrantly activated or mutated, it drives cell proliferation and facilitates metastasis, a dreaded development of cancer. Indeed, mutations in c-Met have been found in some malignancies, including lung adenocarcinomas and small cell lung cancer.
Upon binding of a messenger molecule to c-Met, the protein self-activates and is then able to indirectly switch on other proteins to relay the signal. This is accomplished by a part of c-Met called the kinase domain. Many anticancer drugs function to block the activity of various kinases, by directly binding to that domain. Structural biology has provided us with the 3D structure of c-Met kinase, allowing the characterization of drug-protein interactions at the atomic level. c-Met also has another part called the juxtamembrane region (JMR). The JMR is involved in downregulation of c-Met activity. Part of this regulation is understood, but other aspects are unclear; the JMR can get chemically modified and this event decreases the activity of c-Met kinase. I want to determine the 3D structure of the JMR by x-ray crystallography and study its interaction with the kinase part, in the hope of clarifying how this regulation occurs at the molecular level. I also want to screen a large collection of chemicals to find novel inhibitors of c-Met, since inclusion of the JMR will provide more possibilities for chemical compounds to affect the protein. Understanding how c-Met is regulated would facilitate the development of new molecules to block its function and would ultimately increase our therapeutic arsenal against cancer.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gorelik, Alexei
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~